These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34076849)

  • 1. Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012-2019.
    Boye KS; Lage MJ; Shinde S; Thieu V; Bae JP
    Diabetes Ther; 2021 Jul; 12(7):2077-2087. PubMed ID: 34076849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study.
    Hara K; Hirase T; Pathadka S; Cai Z; Sato M; Ishida N; Takemura R
    Diabetes Ther; 2024 Apr; 15(4):801-817. PubMed ID: 38401022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data.
    Boye KS; Lage MJ; Thieu V; Shinde S; Dhamija S; Bae JP
    J Diabetes Complications; 2021 Sep; 35(9):107975. PubMed ID: 34176723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
    Blonde L; Meneghini L; Peng XV; Boss A; Rhee K; Shaunik A; Kumar S; Balodi S; Brulle-Wohlhueter C; McCrimmon RJ
    Diabetes Ther; 2018 Jun; 9(3):1347-1358. PubMed ID: 29600507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between HbA1c and 1-Year Diabetes-Related Medical Costs: A Retrospective Claims Database Analysis.
    Boye KS; Lage MJ; Thieu VT
    Diabetes Ther; 2022 Feb; 13(2):367-377. PubMed ID: 35129822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.
    Newson RS; Divino V; Boye KS; Chen J; DeKoven M; Vallarino C; Ranta K; Mount JE
    Diabetes Ther; 2024 Jun; 15(6):1435-1449. PubMed ID: 38683494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysis.
    Hu S; Lin C; Cai X; Li Z; Lv F; Yang W; Ji L
    EClinicalMedicine; 2023 Mar; 57():101868. PubMed ID: 36864984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study.
    Boye KS; Bae JP; Thieu VT; Lage MJ
    Diabetes Ther; 2024 Feb; 15(2):395-407. PubMed ID: 38038897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Boye KS; Lage MJ; Kiljański J
    Diabetes Ther; 2021 May; 12(5):1463-1474. PubMed ID: 33837921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Weight Change on Glycemic Control and Metabolic Parameters in T2D: A Retrospective US Study Based on Real-World Data.
    Shinde S; Thieu VT; Kwan AYM; Houghton K; Meyers J; Schapiro D
    Diabetes Ther; 2024 Feb; 15(2):409-426. PubMed ID: 38038898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study.
    Ishigaki Y; Hirase T; Pathadka S; Cai Z; Sato M; Takemura R; Ishida N
    Diabetes Ther; 2024 Jan; 15(1):245-256. PubMed ID: 37856046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective.
    Gelhorn H; Balantac Z; Shinde S; Thieu VT; Boye KS
    Diabetes Ther; 2021 Jul; 12(7):1821-1837. PubMed ID: 34043162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes.
    McKenzie AL; Hallberg SJ; Creighton BC; Volk BM; Link TM; Abner MK; Glon RM; McCarter JP; Volek JS; Phinney SD
    JMIR Diabetes; 2017 Mar; 2(1):e5. PubMed ID: 30291062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus.
    Gouda M; Matsukawa M; Iijima H
    Diabetes Metab Syndr Obes; 2018; 11():647-658. PubMed ID: 30410377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
    Blonde L; Raccah D; Lew E; Meyers J; Nikonova E; Ajmera M; Davis KL; Bertolini M; Guerci B
    Diabetes Ther; 2018 Jun; 9(3):1169-1184. PubMed ID: 29675797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs).
    Desouza C; Kirk AR; Mangla KK; Wolden ML; Lingvay I
    BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33376084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study.
    Peng XV; McCrimmon RJ; Shepherd L; Boss A; Lubwama R; Dex T; Skolnik N; Ji L; Avogaro A; Blonde L
    Diabetes Ther; 2020 Nov; 11(11):2629-2645. PubMed ID: 32902774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening glycemic control in youth with type 2 diabetes during COVID-19.
    Bharill S; Lin T; Arking A; Brown EA; West M; Busin K; Magge SN; Wolf RM
    Front Clin Diabetes Healthc; 2022; 3():968113. PubMed ID: 36992756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.